| Literature DB >> 28154278 |
Luca Foppiani1, Bruno Massobrio, Christian Cascio, Giancarlo Antonucci.
Abstract
Anorexia nervosa (AN) is a serious psychiatric disorder which typically occurs in young women; however, more and more cases in middle-aged women are being reported. The management of this complex disease requires a team approach, and full recovery occurs only in 50% of patients. Endocrine and metabolic complications are commonly observed, the latter of which may even be life-threatening, and require prompt and proper management. Infections, albeit reported, are not usually a major clinical problem in these patients. We herein report the case of a severely malnourished middle-aged woman with long-standing AN who was hospitalized with marked hypokalaemia (1.5 mEq/L) and rhabdomyolysis; during hospitalization she developed septic shock and acute respiratory distress syndrome, which required urgent admission to the intensive care unit. She underwent sedation and tracheal intubation for mechanical ventilation and was managed with combined therapies, which eventually led to a successful outcome. Life-threatening medical complications can occur not only in young women but in middle-aged women with AN as well and require a combined multidisciplinary approach.Entities:
Mesh:
Year: 2017 PMID: 28154278 PMCID: PMC5348458 DOI: 10.2169/internalmedicine.56.7370
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
| Glucose (n.v. 70-115 mg/dL) | 91 | 65 | 71 | 144 | 73 | 78 | 64 | 72 | 56 | 89 | 118 | 194 | 178 | 121 | 119 | 100 | |
| Creatinine (n.v. 0.6-1 mg/dL) | 1.4 | 1.2 | 1.3 | 1.9 | 1.8 | 0.7 | 0.8 | 2.4 | 2.3 | 1.6 | 1.5 | 1.2 | 1.7 | 1.5 | 1.3 | 1.1 | |
| Na (n.v. 135-145 mEq/L) | 125 | 134 | 138 | 133 | 138 | 139 | 137 | 137 | 138 | 146 | 147 | 152 | 145 | 141 | 137 | 138 | |
| K (n.v. 3.5-5 mEq/L) | 1.5 | 2.4 | 2.2 | 2.6 | 4.2 | 4.6 | 4.7 | 4 | 3.2 | 2.9 | 2.9 | 3.6 | 2.7 | 3.9 | 3.9 | 3.8 | |
| AST (n.v. 4-37 IU/L) | 107 | - | 67 | 42 | 71 | 53 | 166 | 77 | 68 | 103 | |||||||
| ALT (n.v. 4-41 IU/L) | 32 | - | 27 | 29 | 32 | 20 | 72 | 52 | 47 | 52 | |||||||
| CPK (n.v. 39-308 IU/L) | 1,159 | 392 | 142 | 48 | 21 | 11 | 10 | 11 | 14 | 12 | |||||||
| Calcium (n.v. 8.2-10.2 mg/dL) | 7 | 7.6 | 8.4 | 9.1 | 8.1 | 7.3 | 7.8 | 8.8 | 9.3 | 9.2 | 9.9 | 9.4 | |||||
| Phosphorus (n.v. 2.7-4.5 mg/dL) | 2.3 | 2.4 | 2 | 5 | |||||||||||||
| Magnesium (1.6-2.6 mg/dL) | 1.4 | 1.5 | 2.1 | 2.9 | |||||||||||||
| White blood cells (n.v. 4,000-11,000/mL) | 12,280 | 6,520 | 4,540 | 5,060 | 6,220 | 7,850 | 7,440 | 4,690 | 4,350 | 11,270 | 17,050 | 22,460 | 24,570 | 22,710 | 19,870 | 14,650 | |
| Neutrophils (n.v. 2,000-8,000/mL) | 10,450 | 4,790 | 2,950 | 2,700 | 3,710 | 5,610 | 4,640 | 3,670 | 3,500 | 9,230 | 14,570 | 18,470 | 22,160 | 19,410 | 17,570 | 13,050 | |
| Haemoglobin (n.v. 14-17 g/dL) | 8.8 | 9.5 | 9.1 | 7.3 | 8.7 | 10.4 | 9.6 | 7.6 | 9 | 11.2 | 13 | 10.9 | 10.2 | 10.3 | 10.3 | 8.7 | |
| Hematocrit (n.v. 42-50%) | 22.8 | 25.9 | 23.9 | 20.3 | 24.8 | 31.5 | 28.4 | 22.6 | 26 | 32.4 | 36.7 | 32.5 | 30.5 | 30.1 | 29.8 | 25.1 | |
| MCV (n.v. 80-96 fL) | 88.4 | 90.6 | 96.5 | 91 | 90.8 | 89.2 | 91.5 | 88.6 | 90.2 | 84.4 | 84 | 88.6 | 86.2 | 85 | 85.9 | 85.7 | |
| Platelets (n.v. 150,000-400,000/mL) | 123,000 | 137,000 | 134,000 | 88,000 | 91,000 | 92,000 | 301,000 | 149,000 | 107,000 | 131,000 | 138,000 | 130,000 | 86,000 | 147,000 | 187,000 | 158,000 | |
| Iron (30-200 μg/dL) | 90 | ||||||||||||||||
| Ferritin (n.v. 30-400 ng/L) | 1,006 | 1,315 | |||||||||||||||
| Prothrombin time (n.v. 70-120%) | 62 | 79 | 42 | 42 | 90 | 80 | 91 | 88 | |||||||||
| Albumin (n.v. 3.5-5.2 g/dL) | 2.3 | 2.5 | 1.7 | 1.2 | 2.1 | 2 | 2.2 | ||||||||||
| Transferrin (n.v. 200-400 mg/dL) | 84 | 66 | |||||||||||||||
| Haptoglobin (30-200 mg/dL) | 104 | ||||||||||||||||
| IGF-I (n.v. for age 90-360 ng/mL) | 52.1 | ||||||||||||||||
| FT4 (n.v. 0.93-1.7 ng/dL) | 0.68 | ||||||||||||||||
| FT3 (n.v. 1.8-4.6 pg/mL) | 0.99 | ||||||||||||||||
| TSH ( n.v. 0.3-4.2μU/mL) | 2.6 | ||||||||||||||||
| LH (7.7-78.5 mIU/mL for menopause) | 77.2 | ||||||||||||||||
| FSH (25.8-134.8 mIU/mL for menopause) | 168.9 | ||||||||||||||||
| 17-beta-estradiol (<20 pg/mL for menopause) | <5 | ||||||||||||||||
| PRL (n.v. 3-20 ng/mL) | 15.8 | ||||||||||||||||
| Cortisol (n.v. 6.2 -19.4μg/dL, 7-10 a.m.) | 14.5 | ||||||||||||||||
| 25-OHD (n.v. > 30 ng/mL) | <4 | ||||||||||||||||
| PTH (n.v. 15-65 pg/mL) | 174.4 | ||||||||||||||||
| CRP (n.v. 0-0.5 mg/dL) | 3.1 | 2.2 | 30.9 | 33.5 | 28 | 26.6 | 9.3 | 11.1 | |||||||||
| PCT (<0.5 ng/mL) | 17.1 | 22.8 | 8.5 | 4.6 | |||||||||||||
| pro-BNP (< 500 pg/mL) | 70,000 | 70,000 | |||||||||||||||
| Ethanol (g/L) | negative | ||||||||||||||||
| HIV test | negative |
(continue)
Figure 1.The patient’s chest X-ray findings throughout hospitalization. On admission, no lung pathologies were observed (a). During hospitalization, the patient developed septic shock and ARDS, and bilateral interstitial pneumonia (mainly in the right middle-basal and left parahilar regions) was found. CVC is visible along the projection of the left subclavian vein (arrow) (b). The lung condition quickly worsened after admission to the ICU, with findings of bilateral diffuse interstitial-alveolar consolidations and no evidence of ventilation (c). Following the initiation of combination therapies, the lung picture partially improved, and bilateral ventilation resumed (d). After extubation, accentuated hilar and perihilar vascular images and reduced transparency due to interstitial-alveolar consolidations, mainly in the right lung, were observed (e). Over the following days, the lung picture markedly improved, with persistence of only minor alveolar consolidations at the middle right site and stasis of the small pulmonary circulation (f). ARDS: acute respiratory distress syndrome, CVC: central venous catheter, ICU: intensive care unit
Figure 2.The patient’s basal CT of the brain showing cerebral atrophy and cerebrovascular disease. CT: computed tomography
continued
| Glucose (n.v. 70-115 mg/dL) | 108 | 94 | 116 | 127 | 96 | 98 | 103 | 107 | 97 | 92 | 87 | 133 | 83 | |||
| Creatinine (n.v. 0.6-1 mg/dL) | 0.9 | 0.9 | 0.7 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | |||
| Na (n.v. 135-145 mEq/L) | 136 | 135 | 137 | 136 | 135 | 133 | 137 | 138 | 134 | 133 | 138 | 136 | 135 | |||
| K (n.v. 3.5-5 mEq/L) | 4.2 | 4.5 | 4.5 | 4.6 | 4.1 | 5 | 4.4 | 4 | 4.2 | 3.6 | 4 | 3.7 | 4.4 | |||
| AST (n.v. 4-37 IU/L) | 125 | 87 | 58 | 37 | 21 | 18 | 13 | 12 | 17 | 15 | ||||||
| ALT (n.v. 4-41 IU/L) | 66 | 57 | 51 | 43 | 19 | 22 | 16 | 15 | 14 | 10 | ||||||
| CPK (n.v. 39-308 IU/L) | 14 | 17 | 10 | 9 | 8 | 8 | 12 | 8 | 17 | 6 | ||||||
| Calcium (n.v. 8.2-10.2 mg/dL) | 9 | 9 | 8.8 | 8.8 | 7.9 | 9.1 | 8.2 | 8.2 | 8.4 | 8.9 | 9.2 | |||||
| Phosphorus (n.v. 2.7-4.5 mg/dL) | 3.7 | |||||||||||||||
| Magnesium (1.6-2.6 mg/dL) | 1.8 | |||||||||||||||
| White blood cells (n.v. 4,000-11,000/mL) | 12,590 | 15,110 | 11,040 | 10,790 | 12,920 | 11,630 | 10,050 | 11,570 | 12,880 | 18,700 | 12,900 | 11,340 | 13,760 | 9,570 | 10,550 | 7,610 |
| Neutrophils (n.v. 2,000-8,000/mL) | 10,800 | 13,780 | 9,190 | 8,590 | 9,910 | 8,730 | 7,760 | 8,770 | 9,480 | 15,730 | 9,400 | 7,100 | 9,050 | 4,610 | 6,800 | 3,590 |
| Haemoglobin (n.v. 14-17 g/dL) | 8.2 | 7.8 | 7 | 8.1 | 7.7 | 7 | 6.6 | 8.8 | 9 | 9.8 | 8.2 | 7.6 | 8.3 | 9.7 | 10 | 9.7 |
| Hematocrit (n.v. 42-50%) | 24.1 | 23.7 | 20.9 | 24 | 23.2 | 21 | 20 | 26.2 | 27 | 29.4 | 24.5 | 23.4 | 25.6 | 29.1 | 29 | 29.7 |
| MCV (n.v. 80-96 fL) | 85.2 | 85.3 | 86 | 86 | 86.6 | 87.5 | 84.4 | 84.5 | 85.2 | 85 | 86.9 | 88 | 88 | 87.1 | 87.5 | 87.6 |
| Platelets (n.v. 150,000-400,000/mL) | 166,000 | 164,000 | 137,000 | 132,000 | 120,000 | 123,000 | 249,000 | 352,000 | 402,000 | 395,000 | 358,000 | 309,000 | 314,000 | 290,000 | 272,000 | 372,000 |
| Iron (30-200 μg/dL) | 9,480 | |||||||||||||||
| Ferritin (n.v. 30-400 ng/L) | ||||||||||||||||
| Prothrombin time (n.v. 70-120%) | 105 | 107 | 101 | 93 | 80 | 99 | 85 | |||||||||
| Albumin (n.v. 3.5-5.2 g/dL) | 2 | 2.1 | 2.3 | |||||||||||||
| Transferrin (n.v. 200-400 mg/dL) | 122 | |||||||||||||||
| Haptoglobin (30-200 mg/dL) | ||||||||||||||||
| IGF-I (n.v. for age 90-360 ng/mL) | 150.5 | |||||||||||||||
| FT4 (n.v. 0.93-1.7 ng/dL) | 0.98 | |||||||||||||||
| FT3 (n.v. 1.8-4.6 pg/mL) | 2.6 | |||||||||||||||
| TSH ( n.v. 0.3-4.2μU/mL) | 1.9 | |||||||||||||||
| LH (7.7-78.5 mIU/mL for menopause) | 38.5 | |||||||||||||||
| FSH (25.8-134.8 mIU/mL for menopause) | 82 | |||||||||||||||
| 17-beta-estradiol (<20 pg/mL for menopause) | <5 | |||||||||||||||
| PRL (n.v. 3-20 ng/mL) | ||||||||||||||||
| Cortisol (n.v. 6.2 -19.4μg/dL, 7-10 a.m.) | 13.1 | |||||||||||||||
| 25-OHD (n.v. > 30 ng/mL) | ||||||||||||||||
| PTH (n.v. 15-65 pg/mL) | ||||||||||||||||
| CRP (n.v. 0-0.5 mg/dL) | 13.4 | 9.1 | 8.4 | 4.9 | 13 | 5.6 | 4.5 | 1.4 | ||||||||
| PCT (<0.5 ng/mL) | 1.87 | 0.88 | 0.4 | 0.2 | ||||||||||||
| pro-BNP (< 500 pg/mL) | 9,838 | 6,788 | ||||||||||||||
| Ethanol (g/L) | ||||||||||||||||
| HIV test |
CRP: C-reactive protein
HT: hemotransfusion
IGF-I: insulin-like growth factor-I
PCT: procalcitonin
pro-BNP: pro-brain natriuretic peptide
IM: internal medicine
ICU: intensive care unit